Concomitant use of other drugs in the same class is generally not recommended duringFuzuloparib administration.
You should follow your doctor’s instructions and not use other medications that may affectFuzuloparib metabolism in combination on your own.
Concomitant use of strong CYP3A4 inhibitors and inducers should be avoided during treatment. If co‑administration is necessary,Fuzuloparib may need to be discontinued or the dosage adjusted.
